BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27721911)

  • 1. Periorbital Hyperpigmentation in Patients with Xanthelasma Palpebrarum: An Interesting Observation.
    Platsidaki E; Kouris A; Agiasofitou E; Antoniou C; Kontochristopoulos G
    J Clin Aesthet Dermatol; 2016 Apr; 9(4):52-54. PubMed ID: 27721911
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular profile of xanthelasma palpebrarum.
    Dey A; Aggarwal R; Dwivedi S
    Biomed Res Int; 2013; 2013():932863. PubMed ID: 23865074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthelasma Palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi.
    Jain A; Goyal P; Nigam PK; Gurbaksh H; Sharma RC
    Indian J Clin Biochem; 2007 Sep; 22(2):151-3. PubMed ID: 23105704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis and clinical significance of xanthelasma palpebrarum.
    Bergman R
    J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):236-42. PubMed ID: 8288783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [KTP laser coagulation for xanthelasma palpebrarum].
    Berger C; Kopera D
    J Dtsch Dermatol Ges; 2005 Oct; 3(10):775-9. PubMed ID: 16194155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [COMBINED THREE OPERATIONS FOR ONE STAGE DEFECTS REPAIR AFTER RESECTION OF LARGE XANTHELASMA PALPEBRARUM WITH EPICANTHUS].
    Zeng L; Chen J; Cen Y; Lei L; Qin X; Wang Y; Zeng C
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Sep; 30(9):1130-1133. PubMed ID: 29786369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining treatment strategies for xanthelasma palpebrarum: a comprehensive literature review of contemporary modalities.
    Yee DA; Zhou AE; Khachemoune A
    Arch Dermatol Res; 2024 May; 316(5):149. PubMed ID: 38724802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthelasma palpebrarum - a brief review.
    Nair PA; Singhal R
    Clin Cosmet Investig Dermatol; 2018; 11():1-5. PubMed ID: 29296091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia in Patients with Xanthelasma Palpebrarum Visiting the Department of Dermatology of a Tertiary Care Centre: A Descriptive Cross-sectional Study.
    Rai A; Karki S; Prasad Sah S; Narayan Kamat L; Pradhan M
    JNMA J Nepal Med Assoc; 2022 Jun; 60(250):529-532. PubMed ID: 35690977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma).
    Pandhi D; Gupta P; Singal A; Tondon A; Sharma S; Madhu SV
    Postgrad Med J; 2012 Apr; 88(1038):198-204. PubMed ID: 22362903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrapulse carbon dioxide laser ablation of xanthelasma palpebrarum: a case series.
    Pathania V; Chatterjee M
    J Cutan Aesthet Surg; 2015; 8(1):46-9. PubMed ID: 25949023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of laser therapy in xanthelasma palpebrarum.
    Nguyen AH; Vaudreuil AM; Huerter CJ
    Int J Dermatol; 2017 Mar; 56(3):e47-e55. PubMed ID: 28181222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of xanthelasma palpebrarum by upper eyelid skin flap incorporating blepharoplasty.
    Yang Y; Sun J; Xiong L; Li Q
    Aesthetic Plast Surg; 2013 Oct; 37(5):882-6. PubMed ID: 23943013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argon laser versus erbium:YAG laser in the treatment of xanthelasma palpebrarum.
    Abdelkader M; Alashry SE
    Saudi J Ophthalmol; 2015; 29(2):116-20. PubMed ID: 25892929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a).
    Ozdöl S; Sahin S; Tokgözoğlu L
    Int J Dermatol; 2008 Aug; 47(8):785-9. PubMed ID: 18717856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipids and risk of atherosclerosis in xanthelasma palpebrarum: A systematic review and meta-analysis.
    Chang HC; Sung CW; Lin MH
    J Am Acad Dermatol; 2020 Mar; 82(3):596-605. PubMed ID: 31499151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma.
    Ribera M; Pintó X; Argimon JM; Fiol C; Pujol R; Ferrándiz C
    Am J Med; 1995 Nov; 99(5):485-90. PubMed ID: 7485205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-wave plasma radiofrequency ablation for treatment of xanthelasma palpebrarum.
    Baroni A
    J Cosmet Dermatol; 2019 Feb; 18(1):121-123. PubMed ID: 29493071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Xanthelasma palpebrarum and dyslipoproteinaemia: two retrospective studies (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loeper J; Bouthillier D; Goussault Y; Dreux C
    Ann Dermatol Venereol; 1982; 109(3):231-5. PubMed ID: 7114736
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.